Compounding Process The pharmacy receives pharmaceutical-grade semaglutide powder and compounds it into injectable solutions in sterile cleanroom environments
Paracetamol (maximum 4 g daily) is a safe first-line option for most patients, whilst ibuprofen (maximum 1.2 g daily for over-the-counter use) may be used if paracetamol proves insufficient, provided you have no contraindications such as kidney disease or gastric ulcer history
To include non-steroidal and anti-inflammatory drugs, such as NSAIDS, as well as most herbal supplements
Additionally, intranasal GHRP-2 has been explored as a long-term therapeutic option, with a one-year intranasal application study showing improvements in body weight and hypoglycemia in a severely malnourished patient (Intranasal GHRP-2, 2015)
Evidence in healthy, non-medical populations is sparse